Clinical Trials Directory

Trials / Completed

CompletedNCT01315054

A Methadone Maintenance Treatment Outcome Study in Three Provinces in China

A Methadone Maintenance Treatment Outcome Study in Three Provinces in China: Comparative Evaluation of the Impact of an Intensive Health Care Provider Training Program

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
4,258 (actual)
Sponsor
Centers for Disease Control and Prevention · Federal
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

The primary goal of this PHE is to determine the effectiveness of a tailored education program for MMT service providers. It was to be evaluated through methadone dose levels prescribed to new patients after training completion. The effects of methadone dose, with and without the inclusion of additional counseling services, would be measured through MMT retention and illicit opioid use.

Detailed description

Methadone treatment has became one of main actions taken in China to control the spread of HIV among drug users. However,the average methadone dose used is relatively low. An intensive methadone maintenance treatment (MMT) provider training on methadone dosage may be effective in increasing the methadone dose levels prescribed to new patients. The study will evaluate the effectiveness of a tailored education program for MMT service providers using subsequent methadone dose prescribed to new patients. The effects of methadone dose, with and without the inclusion of additional psychosocial services, will then be measured through MMT retention and illicit opioid use.

Conditions

Interventions

TypeNameDescription
BEHAVIORALMMT provider dosage trainingTraining on methadone dosing provided to health care providers working in methadone maintenance clinics
BEHAVIORALtargeted counselingtargeted counseling provided to methadone maintenance clinic attendees
OTHERnational guidelinesProvided a hard copy of the existing national guidelines for methadone dosing

Timeline

Start date
2011-05-01
Primary completion
2015-12-01
Completion
2018-12-01
First posted
2011-03-15
Last updated
2024-08-22

Locations

1 site across 1 country: China

Source: ClinicalTrials.gov record NCT01315054. Inclusion in this directory is not an endorsement.